Utilization of Syndromic Vaginitis Diagnostic Testing Reduces 6-Month Follow-Up Outpatient Service Healthcare Costs-A...

Area of Science:

• Women's Health
• Infectious Diseases
• Diagnostic Technologies

Background:

• Vaginitis is a common infection in women of reproductive age.
• Diagnosis often occurs without utilizing available diagnostic tests.
• This gap impacts patient care and healthcare costs.

Purpose of the Study:

• To assess downstream healthcare utilization and costs.
• To compare patients who received diagnostic testing versus those who did not.
• To evaluate the impact of Syndromic Vaginitis PCR testing on healthcare resource use.

Main Methods:

• Retrospective, observational study using IQVIA PharMetrics® Plus database (July 2020-October 2023).
• Two cohorts: patients with vaginitis who received Syndromic Vaginitis PCR testing and those without documented testing.
• Assessed healthcare utilization and costs for 6 months post-index event.

Main Results:

• Patients receiving Syndromic Vaginitis PCR testing had significantly fewer outpatient medical services.
• This led to a substantial decrease in other medical visits.
• Mean cost savings of USD 2067 for patients who received PCR testing compared to those without.

Conclusions:

• Many vaginitis patients do not receive diagnostic testing.
• Syndromic Vaginitis PCR testing is an effective tool for reducing healthcare costs.
• This diagnostic approach can improve the management of vaginitis infections.